STONKWHISPER
← Back to Intel
Insider ActivityAVTX

Sullivan Christopher Ryan, Chief Financial Officer at Avalo Therapeutics, Inc., sold $201K of AVTX

Updated Jun 14, 2026
Sullivan Christopher Ryan Chief Financial Officer
Avalo Therapeutics, Inc. · $AVTX
$201K Total Value
8,900 Shares Traded
$22.5745 Price / Share
423 Shares Owned After
2026-05-07 Filing Date

Transaction Details

InsiderSullivan Christopher Ryan
TitleChief Financial Officer
CompanyAvalo Therapeutics, Inc.
TickerAVTX
Transaction TypeSale
Transaction Date2026-05-06
Shares Traded8,900
Price Per Share$22.5745
Total Value$201K
Filed Date2026-05-07
Accession Number0001810417-26-000010

Ownership Context

Shares Owned After Transaction423
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001810417-26-000010

Other Insider Trades — AVTX

Other Trades by Sullivan Christopher Ryan

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AVTX — Avalo Therapeutics, Inc. →

Track AVTX insider activity in real time on The Wire →

Get alerts when Sullivan Christopher Ryan files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:12 UTC

Want real-time data? Access The Wire for live sentiment tracking.